TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
SPRB

Spruce Biosciences, Inc.

Healthcare · Biotechnology

44.80$ -7.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow SPRB
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– +1,100.0% +200.0% +88.9% +8.8% -5.4% -34.3% -54.3%
– +94.1% +285.2% +424.2% -8.3% +27.3% +15.7% -51.9%
– +94.1% +318.9% +435.0% -16.4% – – –
– -77.8% +342.2% +68.1% -42.1% +814.8% -182.8% –
– +0.0% +1,750.0% +25.7% -91.4% -12.5% -100.0% –
– +0.0% +1,750.0% +106,883.8% – +135.4% – –
– – – – – – – –
– – – -99.9% -129.9% +677.5% – -62.1%
– +0.0% -94.9% +0.0% -100.0% – +0.0% +26.8%
– +0.0% +1,356.1% -99.6% -137.5% – -103.3% –
– – – -174.6% – – -180.4% –
– – – – – – – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?